Technology and Equipment

Aprecia Pharmaceuticals has recently received the first FDA approval for a drug made with 3D printing technology.

Our research team has been investigating innovative manufacturing technologies to develop custom drug delivery systems, and one area of interest for us is 3D printing.

Clive Roberts from the UK's University of Nottingham describes his team's work with big pharma on printing medicines.

The FDA approved the first 3D-printed drug in August; what other hot research projects are set to shape pharma’s 3D future?

Redeploying or selling equipment without sufficient expertise can lead to liability risks.

More quality control testing is needed to ensure that antibiotics don't become targets for fraudsters.

How can we fight the global pandemic of falsified and substandard medicines?

Manufacturing is getting smarter; only a cross-discipline approach will ensure the success of tomorrow’s processes.

When it comes to anti-counterfeiting, you need to go beyond legislation, think ahead, and harness the competitive edge that serialization can offer.

Sitting Down With… James Christie, Project Director for Manufacturing, Association of the British Pharmaceutical Industry (ABPI), London, UK.